Jade Biosciences (JBIO) Non-cash Items (2021 - 2026)

Jade Biosciences (JBIO) has 6 years of Non-cash Items data on file, last reported at $78823.0 in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items fell 71.95% year-over-year to $78823.0; the trailing twelve-month figure through Mar 2026 stood at $78823.0 (down 71.95% YoY), and the FY2025 full-year result was $92693.0, up 743.2% from the prior year.
• Non-cash Items for Q1 2026 stood at $78823.0, down from $92693.0 in the prior quarter.
• Across five years, Non-cash Items topped out at $93.5 million in Q1 2024 and bottomed at $10993.0 in Q4 2024.
• The 5-year median for Non-cash Items is $30.8 million (2022), against an average of $30.9 million.
• The widest annual swing landed in 2024, when Non-cash Items slumped 99.98%; it then soared 244108.33% in 2025.
• A 5-year view of Non-cash Items shows it stood at $82.5 million in 2022, then sank by 39.72% to $49.7 million in 2023, then sank by 99.98% to $10993.0 in 2024, then soared by 743.2% to $92693.0 in 2025, then declined by 14.96% to $78823.0 in 2026.
• The last three Non-cash Items figures came in at $78823.0 (Q1 2026), $92693.0 (Q4 2025), and $29.3 million (Q3 2025), per Business Quant data.

Peer Comparison